{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:01:11Z","timestamp":1762866071759},"reference-count":63,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,12,1]],"date-time":"2012-12-01T00:00:00Z","timestamp":1354320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infection, Genetics and Evolution"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1016\/j.meegid.2012.08.013","type":"journal-article","created":{"date-parts":[[2012,9,6]],"date-time":"2012-09-06T12:15:09Z","timestamp":1346933709000},"page":"1899-1910","source":"Crossref","is-referenced-by-count":9,"title":["Multi-targeted therapy for leprosy: Insilico strategy to overcome multi drug resistance and to improve therapeutic efficacy"],"prefix":"10.1016","volume":"12","author":[{"given":"Shanmugam","family":"Anusuya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeyakumar","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.meegid.2012.08.013_b0005","doi-asserted-by":"crossref","first-page":"961","DOI":"10.4155\/fmc.11.62","article-title":"Computational tools for polypharmacology and repurposing","volume":"3","author":"Achenbach","year":"2011","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.meegid.2012.08.013_b0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/nar\/28.1.45","article-title":"The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000","volume":"28","author":"Bairoch","year":"2000","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.meegid.2012.08.013_b0015","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1574-6976.2008.00104.x","article-title":"Cytoplasmic steps of peptidoglycan biosynthesis","volume":"32","author":"Barreteau","year":"2008","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.meegid.2012.08.013_b0020","doi-asserted-by":"crossref","first-page":"11556","DOI":"10.1021\/bi970797f","article-title":"Invariant amino acids in the Mur peptide synthetases of bacterial peptidoglycan synthesis and their modification by site-directed mutagenesis in the UDP-MurNAc: l-alanine ligase from Escherichia coli","volume":"36","author":"Bouhss","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.meegid.2012.08.013_b0025","doi-asserted-by":"crossref","first-page":"12240","DOI":"10.1021\/bi990517r","article-title":"Role of the ortholog and paralog amino acid invariants in the active site of the UDP-MurNAc-l-alanine: d-glutamate Ligase (MurD)","volume":"38","author":"Bouhss","year":"1999","journal-title":"Biochemistry"},{"key":"10.1016\/j.meegid.2012.08.013_b0030","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1042\/bst0250188","article-title":"Structure, function and biogenesis of the mycobacterial cell wall","volume":"25","author":"Brennan","year":"1997","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.meegid.2012.08.013_b0035","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1128\/JVI.79.1.554-568.2005","article-title":"Evolutionary trace residues in noroviruses: importance in receptor binding, antigenicity, virion assembly, and strain diversity","volume":"79","author":"Chakravarty","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.meegid.2012.08.013_b0040","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.2174\/138161210792389207","article-title":"Review of QSAR models for enzyme classes of drug targets: theoretical background and applications in parasites, hosts, and other organisms","volume":"16","author":"Concu","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.meegid.2012.08.013_b0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2958.2003.03289.x","article-title":"Structure and function of the Mur enzymes: development of novel inhibitors","volume":"47","author":"El Zoeiby","year":"2003","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.meegid.2012.08.013_b0050","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/S0960-894X(98)00285-6","article-title":"Inhibitors of the bacterial cell wall biosynthesis enzyme Mur D","volume":"8","author":"Gegnas","year":"1998","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.meegid.2012.08.013_b0055","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s11030-010-9280-3","article-title":"First computational chemistry multi-target model for anti-Alzheimer, anti-parasitic, anti-fungi, and anti-bacterial activity of GSK-3 inhibitors in vitro, in vivo, and in different cellular lines","volume":"15","author":"Garc\u00eda","year":"2011","journal-title":"Mol. Divers."},{"key":"10.1016\/j.meegid.2012.08.013_b0060","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2174\/138920010791514225","article-title":"Review of MARCH-INSIDE & complex networks prediction of drugs: ADMET, anti-parasite activity, metabolizing enzymes and cardiotoxicity proteome biomarkers","volume":"11","author":"Gonz\u00e1lez-D\u00edaz","year":"2010","journal-title":"Curr. Drug. Metab."},{"key":"10.1016\/j.meegid.2012.08.013_b0065","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1021\/pr101009e","article-title":"MIND-BEST: web server for drugs and target discovery; design, synthesis, and assay of MAO-B inhibitors and theoretical\u2013experimental study of G3PDH protein from Trichomonas gallinae","volume":"10","author":"Gonz\u00e1lez-D\u00edaz","year":"2011","journal-title":"J. Proteome. Res."},{"key":"10.1016\/j.meegid.2012.08.013_b0070","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jtbi.2011.01.010","article-title":"NL MIND-BEST: a web server for ligands and proteins discovery-theoretic-experimental study of proteins of Giardia lamblia and new compounds active against Plasmodium falciparum","volume":"276","author":"Gonz\u00e1lez-D\u00edaz","year":"2011","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.meegid.2012.08.013_b0075","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1128\/MMBR.00028-07","article-title":"Bacterial growth and cell division: a mycobacterial perspective","volume":"72","author":"Hett","year":"2008","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.meegid.2012.08.013_b0080","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1128\/jb.172.2.1005-1013.1990","article-title":"Peptidoglycan-associated polypeptides of Mycobacterium tuberculosis","volume":"172","author":"Hirschfield","year":"1990","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.meegid.2012.08.013_b0085","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1016\/j.tet.2006.08.030","article-title":"A new approach towards peptidosulfonamides: synthesis of potential inhibitors of bacterial peptidoglycan biosynthesis enzymes MurD and MurE","volume":"62","author":"Humljan","year":"2006","journal-title":"Tetrahedron"},{"key":"10.1016\/j.meegid.2012.08.013_b0090","doi-asserted-by":"crossref","first-page":"7486","DOI":"10.1021\/jm800762u","article-title":"Novel naphthalene-N-sulfonyl-d-glutamic acid derivatives as inhibitors of MurD, a key peptidoglycan biosynthesis enzyme","volume":"51","author":"Humljan","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.meegid.2012.08.013_b0095","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.2174\/138161207781368828","article-title":"Development of novel inhibitors targeting intracellular steps of peptidoglycan biosynthesis","volume":"13","author":"Kotnik","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.meegid.2012.08.013_b0100","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jmb.2007.04.048","article-title":"Structural and functional characterization of enantiomeric glutamic acid derivatives as potential transition state analogue inhibitors of MurD ligase","volume":"370","author":"Kotnik","year":"2007","journal-title":"Mol. Biol."},{"key":"10.1016\/j.meegid.2012.08.013_b0105","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0022-2836(71)90324-X","article-title":"The interpretation of protein structures: estimation of static accessibility","volume":"55","author":"Lee","year":"1971","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.meegid.2012.08.013_b0110","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1006\/jmbi.1996.0167","article-title":"An evolutionary trace method defines binding surfaces common to protein families","volume":"257","author":"Lichtarge","year":"1996","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.meegid.2012.08.013_b0115","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0959-440X(02)00284-1","article-title":"Evolutionary predictions of binding surfaces and interactions","volume":"12","author":"Lichtarge","year":"2002","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.meegid.2012.08.013_b0120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1074\/mcp.M100004-MCP200","article-title":"Getting more from less: algorithms for rapid protein identification with multiple short peptide sequences","volume":"1","author":"Mackey","year":"2002","journal-title":"Mol. Cell Proteome."},{"key":"10.1016\/j.meegid.2012.08.013_b0125","doi-asserted-by":"crossref","first-page":"3635","DOI":"10.1128\/AAC.45.12.3635-3639.2001","article-title":"Multi drug resistant Mycobacterium leprae from patients with leprosy","volume":"45","author":"Maeda","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2012.08.013_b0130","doi-asserted-by":"crossref","first-page":"6827","DOI":"10.1128\/JB.182.23.6827-6830.2000","article-title":"Comparison of the UDP-N-acetylmuramate: l-alanine ligase enzymes from Mycobacterium tuberculosis and Mycobacterium leprae","volume":"182","author":"Mahapatra","year":"2000","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.meegid.2012.08.013_b0135","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1128\/JB.00982-07","article-title":"Unique structural features of the peptidoglycan of Mycobacterium leprae","volume":"190","author":"Mahapatra","year":"2008","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.meegid.2012.08.013_b0140","doi-asserted-by":"crossref","first-page":"12207","DOI":"10.1021\/bi015567m","article-title":"Biochemical characterization of a phosphinate inhibitor of Escherichia coli MurC","volume":"40","author":"Marmor","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.meegid.2012.08.013_b0145","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.ejmech.2011.02.072","article-title":"Using the TOPS-MODE approach to fit multi-target QSAR models for tyrosine kinases inhibitors","volume":"46","author":"Marzaro","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.meegid.2012.08.013_b0150","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0022-2836(03)00663-6","article-title":"Combining inference from evolution and geometric probability in protein structure evaluation","volume":"331","author":"Mihalek","year":"2003","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.meegid.2012.08.013_b0155","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1039\/a704097k","article-title":"Aminoalkylphosphinate inhibitors of d-Ala-d-Ala adding enzyme","volume":"1","author":"Miller","year":"1998","journal-title":"J. Chem. Soc. Perkin."},{"issue":"2","key":"10.1016\/j.meegid.2012.08.013_b0160","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1128\/AAC.01212-10","article-title":"Mutation analysis of the Mycobacterium leprae folP1 gene and dapsone resistance","volume":"55","author":"Nakata","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"issue":"4","key":"10.1016\/j.meegid.2012.08.013_b0165","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1128\/AAC.05831-11","article-title":"Mutation analysis of mycobacterial rpoB genes and rifampin resistance using recombinant Mycobacterium smegmatis","volume":"56","author":"Nakata","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.meegid.2012.08.013_b0170","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.tips.2011.08.004","article-title":"Allo-network drugs: harnessing allostery in cellular networks","volume":"32","author":"Nussinov","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.meegid.2012.08.013_b0175","doi-asserted-by":"crossref","first-page":"W239","DOI":"10.1093\/nar\/gkl190","article-title":"CUPSAT: prediction of protein stability upon point mutations","volume":"34","author":"Parthiban","year":"2006","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.meegid.2012.08.013_b0180","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1016\/j.bmcl.2009.03.141","article-title":"Discovery of novel benzene 1,3-dicarboxylic acid inhibitors of bacterial MurD and MurE ligases by structure-based virtual screening approach","volume":"19","author":"Perdih","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.meegid.2012.08.013_b0185","doi-asserted-by":"crossref","first-page":"5871","DOI":"10.1016\/j.bmc.2008.04.068","article-title":"Unified QSAR approach to antimicrobials. Part 3: first multi-tasking QSAR model for input-coded prediction, structural back-projection, and complex networks clustering of antiprotozoal compounds","volume":"16","author":"Prado-Prado","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.meegid.2012.08.013_b0190","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.bmc.2008.11.075","article-title":"Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug\u2013drug complex networks","volume":"17","author":"Prado-Prado","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.meegid.2012.08.013_b0195","doi-asserted-by":"crossref","first-page":"4516","DOI":"10.1016\/j.ejmech.2009.06.018","article-title":"Multi-target spectral moments for QSAR and complex networks study of antibacterial drugs","volume":"44","author":"Prado-Prado","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.meegid.2012.08.013_b0200","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/j.bmc.2010.01.068","article-title":"Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species","volume":"18","author":"Prado-Prado","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.meegid.2012.08.013_b0205","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.ejmech.2011.01.023","article-title":"Using entropy of drug and protein graphs to predict FDA drug-target network: theoretic\u2013experimental study of MAO inhibitors and hemoglobin peptides from Fasciola hepatica","volume":"46","author":"Prado-Prado","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.meegid.2012.08.013_b0210","doi-asserted-by":"crossref","first-page":"5838","DOI":"10.1016\/j.ejmech.2011.09.045","article-title":"2D MI-DRAGON: a new predictor for protein\u2013ligands interactions and theoretic\u2013experimental studies of US FDA drug-target network, oxoisoaporphine inhibitors for MAO-A and human parasite proteins","volume":"46","author":"Prado-Prado","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.meegid.2012.08.013_b0215","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/nrd3478","article-title":"Trends in the exploitation of novel drug targets","volume":"10","author":"Rask-Andersen","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.meegid.2012.08.013_b0220","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/S0960-894X(01)00251-7","article-title":"Inhibitors of the bacterial cell wall biosynthesis enzyme MurC","volume":"11","author":"Reck","year":"2001","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"6","key":"10.1016\/j.meegid.2012.08.013_b0225","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1128\/JCM.06561-11","article-title":"Drug and multiple-drug resistance among Mycobacterium leprae isolates from Brazilian relapsed leprosy patients","volume":"50","author":"Rocha Ada","year":"2012","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.meegid.2012.08.013_b0230","doi-asserted-by":"crossref","first-page":"392","DOI":"10.6026\/97320630004392","article-title":"Computational genome analyses of metabolic enzymes in Mycobacterium leprae for drug target identification","volume":"4","author":"Shanmugam","year":"2010","journal-title":"Bioinformation"},{"key":"10.1016\/j.meegid.2012.08.013_b0235","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s00894-011-1039-y","article-title":"Comparative modeling of UDP-N-acetylmuramoyl-glycyl-d-glutamate-2,6-diaminopimelate ligase from Mycobacterium leprae and analysis of its binding features through molecular docking studies","volume":"18","author":"Shanmugam","year":"2012","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.meegid.2012.08.013_b0240","doi-asserted-by":"crossref","first-page":"2659","DOI":"10.1007\/s00894-011-1285-z","article-title":"Homology modeling and docking analyses of M. leprae Mur ligases reveals the common binding residues for structure based drug designing to eradicate leprosy","volume":"18","author":"Shanmugam","year":"2012","journal-title":"J. Mol. Model."},{"key":"10.1016\/j.meegid.2012.08.013_b0245","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bioorg.2009.09.001","article-title":"Phosphorylated hydroxyethylamines as novel inhibitors of the bacterial cell wall biosynthesis enzymes MurC to MurF","volume":"37","author":"Sova","year":"2009","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.meegid.2012.08.013_b0250","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/84974","article-title":"Prediction and confirmation of a site critical for effector regulation of RGS domain activity","volume":"8","author":"Sowa","year":"2001","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.meegid.2012.08.013_b0255","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.bmcl.2005.09.086","article-title":"Design, synthesis and structure\u2013activity relationships of new phosphinate inhibitors of MurD","volume":"16","author":"Strancar","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.meegid.2012.08.013_b0260","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/ardp.200600191","article-title":"Phosphinate inhibitors of UDP-N-acetylmuramoyl-l-alanyl-d-glutamate: l-lysine ligase (MurE)","volume":"340","author":"Strancar","year":"2007","journal-title":"Arch. Pharm. (Weinheim)."},{"key":"10.1016\/j.meegid.2012.08.013_b0265","doi-asserted-by":"crossref","first-page":"6239","DOI":"10.1016\/j.bmc.2011.09.015","article-title":"Multi-target drug discovery in anti-cancer therapy: fragment-based approach toward the design of potent and versatile anti-prostate cancer agents","volume":"19","author":"Speck-Planche","year":"2011","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.meegid.2012.08.013_b0270","article-title":"Chemoinformatics in multi-target drug discovery for anti-cancer therapy: in silico design of potent and versatile anti-brain tumor agents","volume":"11","author":"Speck-Planche","year":"2011","journal-title":"Anticancer Agents Med. Chem."},{"key":"10.1016\/j.meegid.2012.08.013_b0275","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.2174\/138161210792389289","article-title":"Current pharmaceutical design of antituberculosis drugs: future perspectives","volume":"16","author":"Speck-Planche","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.meegid.2012.08.013_b0280","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1021\/jo951780a","article-title":"Phosphinate inhibitors of the d-glutamic acid-adding enzyme of peptidoglycan biosynthesis","volume":"61","author":"Tanner","year":"1996","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.meegid.2012.08.013_b0285","doi-asserted-by":"crossref","first-page":"4673","DOI":"10.1093\/nar\/22.22.4673","article-title":"CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice","volume":"22","author":"Thompson","year":"1994","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.meegid.2012.08.013_b0290","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/cmdc.200900449","article-title":"5-Benzylidenethiazolidin-4-ones as multi target inhibitors of bacterial Mur ligases","volume":"5","author":"Tomasic","year":"2010","journal-title":"ChemMedChem"},{"key":"10.1016\/j.meegid.2012.08.013_b0295","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.bmc.2009.01.052","article-title":"Discovery of new inhibitors of the bacterial peptidoglycan biosynthesis enzymes MurD and MurF by structure-based virtual screening","volume":"17","author":"Turk","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.meegid.2012.08.013_b0300","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1021\/mp800102c","article-title":"Alignment-free prediction of a drug-target complex network based on parameters of drug connectivity and protein sequence of receptors","volume":"6","author":"Vi\u00f1a","year":"2009","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.meegid.2012.08.013_b0305","unstructured":"World Health Organization, 1995. A guide to eliminating leprosy as a public health problem. WHO\/LEP\/95.1."},{"key":"10.1016\/j.meegid.2012.08.013_b0310","first-page":"389","article-title":"Leprosy update","volume":"86","year":"2011","journal-title":"Wkly. Epidemiol. Rec."},{"key":"10.1016\/j.meegid.2012.08.013_b0315","doi-asserted-by":"crossref","first-page":"10081","DOI":"10.1021\/jo981895p","article-title":"A phosphinate inhibitor of the meso-diaminopimelic acid-adding enzyme (MurE) of peptidoglycan biosynthesis","volume":"63","author":"Zeng","year":"1998","journal-title":"J. Org. Chem."}],"container-title":["Infection, Genetics and Evolution"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134812002821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567134812002821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,20]],"date-time":"2018-11-20T20:31:02Z","timestamp":1542745862000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567134812002821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,12]]},"references-count":63,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["S1567134812002821"],"URL":"https:\/\/doi.org\/10.1016\/j.meegid.2012.08.013","relation":{},"ISSN":["1567-1348"],"issn-type":[{"value":"1567-1348","type":"print"}],"subject":[],"published":{"date-parts":[[2012,12]]}}}